Terbinafine HCl Recalled for Potential Penicillin Cross-Contamination
Attix Pharmaceuticals is recalling Terbinafine HCl active pharmaceutical ingredient due to potential cross-contamination with penicillin during repackaging.
- Product
- Terbinafine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
- Category
- Drug
- Distribution
- Distributed nationwide